基于62项纵向全基因组关联研究荟萃分析得出的肾功能下降遗传位点及基因优先级
该研究对62项纵向研究中的343,339名个体进行每年eGFR下降率的全基因组关联分析及荟萃分析,识别出12个与eGFR下降相关的全基因组显著独立变异,其中9个在不同模型中稳健关联,且这些位点均已知与横断面eGFR相关;不利的九变异遗传谱与肾衰竭风险比值比1.35(95%CI 1.03-1.77)及急性肾损伤风险比值比1.27(95%CI 1.08-1.50)相关。
要点
- 识别出12个与每年eGFR下降相关的全基因组显著独立变异,其中11个为新发现,1个为该表型已知。
- 9个变异在未调整或调整基线eGFR的模型中稳健关联,且均已知与横断面eGFR相关。
- 高危亚组中eGFR下降的遗传效应增大2至4倍;不利九变异遗传谱与肾衰竭和急性肾损伤风险升高相关。
核心结论
- 研究提供了大规模数据资源、遗传位点和优先基因,有助于指导药物开发管线,并揭示肾功能遗传学的年龄依赖性。
研究设计与样本
- 对62项纵向研究进行每年eGFR下降率的全基因组关联分析及荟萃分析,纳入343,339名个体,eGFR均至少两次随时间评估,并探索了不同协变量调整。
主要发现
- 识别出12个与eGFR下降相关的全基因组显著独立变异(11个新发现,1个为该表型已知),其中9个在未调整或调整基线eGFR的模型中稳健关联。
- 9个稳健变异中有7个显示与年龄交互作用于横断面eGFR(进一步涉及约350,000名个体),将eGFR下降的遗传关联与遗传横断面关联的年龄依赖性联系起来。
- 高危亚组中eGFR下降的遗传效应增大2至4倍。
- 5个变异同时与慢性肾脏病进展相关,定位至具有计算机功能证据的基因(UMOD、SPATA7、GALNTL5、TPPP)。
- 不利与有利的九变异遗传谱相比,肾衰竭风险比值比1.35(95%CI 1.03-1.77),急性肾损伤风险比值比1.27(95%CI 1.08-1.50),各超过2000例病例并匹配对照。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Estimated glomerular filtration rate (eGFR) reflects kidney function. Progressive eGFR-decline can lead to kidney failure, necessitating dialysis or transplantation. Hundreds of loci from genome-wide association studies (GWAS) for eGFR help explain population cross section variability. Since the contribution of these or other loci to eGFR-decline remains largely unknown, we derived GWAS for annual eGFR-decline and meta-analyzed 62 longitudinal studies with eGFR assessed twice over time in all 343,339 individuals and in high-risk groups. We also explored different covariate adjustment. Twelve genome-wide significant independent variants for eGFR-decline unadjusted or adjusted for eGFR-baseline (11 novel, one known for this phenotype), including nine variants robustly associated across models were identified. All loci for eGFR-decline were known for cross-sectional eGFR and thus distinguished a subgroup of eGFR loci. Seven of the nine variants showed variant-by-age interaction on eGFR cross section (further about 350,000 individuals), which linked genetic associations for eGFR-decline with age-dependency of genetic cross-section associations. Clinically important were two to four-fold greater genetic effects on eGFR-decline in high-risk subgroups. Five variants associated also with chronic kidney disease progression mapped to genes with functional in-silico evidence (UMOD, SPATA7, GALNTL5, TPPP). An unfavorable versus favorable nine-variant genetic profile showed increased risk odds ratios of 1.35 for kidney failure (95% confidence intervals 1.03-1.77) and 1.27 for acute kidney injury (95% confidence intervals 1.08-1.50) in over 2000 cases each, with matched controls). Thus, we provide a large data resource, genetic loci, and prioritized genes for kidney function decline, which help inform drug development pipelines revealing important insights into the age-dependency of kidney function genetics.
引用
- Gorski M, Rasheed H, Teumer A, et al. Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies. Kidney Int. 2022. PMID: 35716955. doi:10.1016/j.kint.2022.05.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。